SCOPE Summit for Clinical Ops Executives
Talk Quality & Monitoring track
Debate: Fraud and Misconduct in Clinical Trials: Marginal Nuisance or Major Problem?
Wed, Feb 5, 2025 · 9:35–9:55 AM EST Rosen Shingle Creek
About this session
Misconduct cases in clinical trials world get significant attention. Are the discovered and publicized situations a tip of an iceberg or isolated incidents? During the session, two experienced RBQM leaders: Marcin Makowski, GSK and Jonathan Rowe, ZS will clash in a debate on the topic of scale and importance of fraud and misconduct.
